iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics. It focuses on the development of precision antibodies. The company was founded on April 17, 2008 and is headquartered in Bryan, TX.
The current price of IBIO is 1.89 USD — it has decreased by 3.08% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on AMEX exchange iBio, Inc. stocks are traded under the ticker IBIO.
iBio, Inc. is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
IBIO earnings for the last quarter are −68.40 USD whereas the estimation was −146.90 USD which accounts for 53.44% surprise. Estimated earnings for the next quarter are −7.20 USD. See more details about iBio, Inc. earnings.
iBio, Inc. revenue for the last quarter amounts to 0 USD despite the estimated figure of 600.00 K USD. In the next quarter revenue is expected to reach 200.00 K USD.
Yes, you can track iBio, Inc. financials in yearly and quarterly reports right on TradingView.
IBIO stock has fallen by 11.27% compared to the previous week, the month change is a 76.64% rise, over the last year iBio, Inc. has showed a 90.74% decrease.
Like other stocks, IBIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade iBio, Inc. stock right from TradingView charts — choose your broker and connect to your account.
IBIO reached its all-time high on Jan 18, 2011 with the price of 30300.00 USD, and its all-time low was 1.02 USD and was reached on Jan 18, 2024. See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has 26.00 employees. See our rating of the largest employees — is iBio, Inc. on this list?